Gazette.govt.nzIn the notice with the above heading, published in the New Zealand Gazette, 16 January 2020, Notice No. 2020-go153.
This corrigendum amends the notice by replacing the entries:
| Product: | Amoxiclav-Duo |
| Active Ingredients: | Amoxicillin trihydrate 91.84mg/mL Potassium clavulanate 27.154mg/mL |
| Dosage Form: | Powder for oral suspension |
| New Zealand Sponsor: | Devatis Limited |
| Manufacturer: | Deva Holding AS, Tekirdag, Turkey |
| Product: | Amoxiclav-Forte |
| Active Ingredients: | Amoxicillin trihydrate 57.4mg/mL Potassium clavulanate 29.776mg/mL |
| Dosage Form: | Powder for oral suspension |
| New Zealand Sponsor: | Devatis Limited |
| Manufacturer: | Deva Holding AS, Tekirdag, Turkey |
With:
| Product: | Amoxiclav Devatis Duo |
| Active Ingredients: | Amoxicillin trihydrate 91.84mg/mL Potassium clavulanate 27.154mg/mL |
| Dosage Form: | Powder for oral suspension |
| New Zealand Sponsor: | Devatis Limited |
| Manufacturer: | Deva Holding AS, Tekirdag, Turkey |
| Product: | Amoxiclav Devatis Forte |
| Active Ingredients: | Amoxicillin trihydrate 57.4mg/mL Potassium clavulanate 29.776mg/mL |
| Dosage Form: | Powder for oral suspension |
| New Zealand Sponsor: | Devatis Limited |
| Manufacturer: | Deva Holding AS, Tekirdag, Turkey |
Dated this 21st day of January 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).